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Self-tolerance by clonal anergy of B cells is marked by an increase in IgD and decrease in IgM
antigen receptor surface expression, yet the function of IgD on anergic cells is obscure. Here
we define the RNA landscape of the in vivo anergy response, comprising 220 induced
sequences including a core set of 97. Failure to co-express IgD with IgM decreases overall
expression of receptors for self-antigen, but paradoxically increases the core anergy response,
exemplified by increased Sdc1 encoding the cell surface marker syndecan-1. IgD expressed on
its own is nevertheless competent to induce calcium signalling and the core anergy mRNA
response. Syndecan-1 induction correlates with reduction of surface IgM and is exaggerated
without surface IgD in many transitional and mature B cells. These results show that IgD
attenuates the response to self-antigen in anergic cells and promotes their accumulation.
In this way, IgD minimizes tolerance-induced holes in the pre-immune antibody repertoire.
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C
lonal anergy is an enigmatic mechanism for actively
acquired tolerance, a process in which self-reactive
cells remain in the lymphocyte repertoire of secondary
lymphoid tissues but are deficient in generation of effector
progeny1,2. Anergy is best characterized in mouse and human
peripheral B cells expressing high cell surface levels of IgD
and low levels of IgM B cell receptors (BCR), which account for
10–50% of the mature pre-immune B cell repertoire, depending
on an arbitrary cut-off for low surface IgM (refs 3–7).
Retaining anergic B cells bearing self-binding antibodies in
the secondary lymphoid organs presents a risk of autoimmunity8,
as the diminished proliferation and antibody secretion that
characterizes anergic B cells is potentially reversible2,9.
Pathological proliferation of B cells that would normally be
anergic also leads to common adult malignancies, exemplified
by a large subgroup of chronic lymphocytic leukaemia cases10,
and by the over-representation of B cells using self-reactive
VH4-34 heavy chains, which are normally anergic, within the
poor prognosis subset of diffuse large B cell lymphoma11. By
contrast, physiological proliferation of B cells that were initially
anergic has been shown to occur when these cells bind a
foreign antigen recognized by T-follicular helper cells and
produce germinal centre (GC) progeny and IgG antibodies that
have been hypermutated away from self-reactivity12,13. The
molecular nature of B cell anergy that precedes any reactivation
into proliferation nevertheless remains unresolved, in particular
whether or not anergy is explained by binding antigen primarily
through IgD antigen receptors.
Anergic cells selectively inhibit trafficking of nascent IgM but
not IgD through the trans-Golgi network to the cell surface14.
A similar change in IgM trafficking occurs in malignant B cells in
chronic lymphocytic leukaemia15 and during normal maturation
of B cells in the spleen16. This altered trafficking may be explained
by the IgD juxtamembrane and transmembrane segments—one
of the few evolutionarily conserved domains of IgD (ref. 17)—
associating preferentially with the CD79ab subunits needed for
IgM and IgD trafficking and signalling on the cell surface18–21.
Immature B cells begin by expressing only IgM, but IgD
co-expression progressively increases as they become
transitional and mature B cells in the spleen due to increased
expression of Zfp318 (ref. 22), which facilitates alternative mRNA
splicing of the heavy chain variable (VDJH) exon to either IgM or
IgD heavy chain constant (C)-region exons. This arrangement is
evolutionarily preserved in most species of fish, amphibians,
reptiles, birds and mammals17,23, yet mice lacking IgD have
normal B cell development and only slightly delayed antibody
responses24,25. Likewise, comparison of mice that express only
IgM or only IgD reveals no discernable difference in the capacity
of these alternative receptors to promote B cell development,
tolerance, activation or antibody secretion in vivo26,27.
Conflicting results from tissue culture experiments support the
idea that IgM and IgD signal differently. Early experiments
suggested that IgM signals drive apoptosis whereas IgD signals
induce proliferation, so that immature IgM-only B cells would
pass through a window of obligate tolerance susceptibility28,29.
However, these differences might reflect the use of different
antibody ligands to engage IgM and IgD, rather than an intrinsic
difference in the receptor isotypes. In transfected B lymphoma
cells, a single haptenated antigen signalled through IgD
more strongly and durably than through IgM30. By contrast,
hen egg lysozyme (HEL) antigen signalling induced CD86
identically through IgD or IgM on splenic B cells expressing
one or other isotype21. However, when the same IgMHEL and
IgDHEL BCRs were expressed separately in a pro-B cell line with a
partially crippled BLNK (SLP65) intracellular signalling
adaptor, soluble monovalent HEL antigen signalled an increase
in intracellular calcium when it bound IgM but induced no
calcium signalling when it bound IgD, whereas multivalent
HEL-antigen signalled through both isotypes31. Extrapolating
the findings from the BLNK mutant cell line, it was concluded
that the predominant expression of IgD on anergic cells prevents
any response to monovalent self-antigens, ascribing the in vivo
state of anergy to the change in BCR isotype31.
Here we directly address the role of IgD on anergic B cells
in vivo with three complementary approaches, by analysing
anergic B cells in mice either lacking IgD, with a novel point
mutation in IgD, or inactivation of the IgD-splicing factor Zfp318.
We find little intrinsic signalling difference between the
two receptor isotypes, but IgD has an essential function when
co-expressed with IgM, attenuating the in vivo response to self
and promoting accumulation of mature anergic B cells to increase
their availability to encounter foreign antigens and potentially
form GCs.
Results
Calcium signalling by IgD and IgM. We first tested the proposal
that IgD is unable to trigger an acute elevation of intracellular
calcium in response to monomeric antigens like soluble HEL
(ref. 31), potentially explaining the unresponsive state of anergic B
cells. The intracellular calcium increase elicited by monomeric
HEL was directly compared in splenic B cells from MM4 and DD6
transgenic mice, which respectively express the IgMHEL or IgDHEL
antigen receptors studied in ref. 31 comprising identical variable
regions and different constant regions. In contrast to the findings
made in BLNK-mutant pro-B cells31, when tested here in mature B
cells with normal BLNK both isotypes signalled an acute and
sustained calcium response (Fig. 1), although the initial rise in
calcium was slightly decreased in cells with IgDHEL antigen
receptors.
IgD enhances formation of GC cells from anergic B cells.
Although IgD expression ceases on activated and GC B cells, we
investigated if IgD had any role in the reactivation of anergic
B cells using an animal model where anergic B cells have been
shown to be reactivated by foreign antigen to form GC progeny,
hypermutate their V-regions and rapidly evolve antibodies with
lower affinity for self-antigen12. HEL-specific anergic B cells were
obtained from MD4:ML5 animals that co-express IgDHEL
with IgMHEL, or from MM4:ML5 animals where the heavy
chain transgene lacks the IgD exons and encodes only IgMHEL.
The mice also carried the ML5 transgene producing circulating
HEL at sufficient concentration to induce B cell anergy1,26. Naı¨ve
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Figure 1 | IgD and IgM both signal intracellular calcium upon binding
monovalent antigen. Mixtures of splenic naı¨ve B cells from DD6 CD45.2
mice expressing only IgDHEL and MM4 CD45.1 heterozygous mice with only
IgMHEL were loaded with the intracellular calcium indicator, Indo-1 and
analysed by flow cytometry using gating strategy shown in Supplementary
Fig. 1. Arrows indicate when HEL (5mgml 1) or ionomycin was added. Results
are representative of three stimulations and two independent experiments
with MM4 and DD6 mice of reversed CD45.1/CD45.2 genotypes.
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(non-anergic) control B cells with or without IgD were
obtained from MD4 or MM4 single-transgenic mice. After
labelling with CFSE dye, equal numbers of splenic B cells
bearing the CD45.1 congenic marker were adoptively
transferred into C57BL/6 (CD45.2) mice. The recipients were
immunized with HEL coupled to sheep red blood cells, the
latter eliciting T follicular helper cells to form GCs (HEL-SRBC).
At the time of transfer, IgDþ anergic B cells had three
times more HEL-specific antigen receptors on their surface
compared with anergic IgM-only B cells (red versus orange
histograms, Fig. 2a).
Half of the recipients were analysed after 2.5 days. The progeny
of naı¨ve control B cells had divided and diluted CFSE comparably
with or without IgD (Fig. 2b, unshaded blue versus green
histograms), 90% diluting by more than 4 cell divisions (Fig. 2c).
By comparison, 75% of IgDþ and 55% of IgD-deficient
anergic cell progeny had divided 4four times (red and orange
histograms, Fig. 2b,c). The total number of progeny from
IgD-deficient anergic cells was decreased to only 20% of naı¨ve
controls by day 2.5 (Fig. 2d), whereas progeny of IgDþ anergic
cells accumulated to the same number as controls.
The remainder of the recipients were analysed after 5 days.
FasþGL7þGC B cells in the spleen averaged 2.6% of B cells and
were not significantly different between the groups of recipients,
and CD45.1þ HEL-binding donor GC B cells accounted for 9%
of GC cells averaged across the groups. However, anergic IgDþ
B cells formed more GC progeny than naı¨ve IgDþ counterparts,
as observed previously12, but the opposite was observed for
anergic B cells without IgD, which formed many fewer GC
progeny than their naı¨ve counterparts (orange bar, Fig. 2e).
By contrast, IgD-deficiency did not alter the number of GC
progeny formed from naı¨ve B cells on day 5 (green bar).
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Figure 2 | IgD promotes accumulation of mature anergic B cells and germinal centre cell progeny. (a–e) Adoptive transfer of equal numbers of CFSE-
loaded CD45.1þ spleen B cells, either naive B cells from MD4 transgenic mice co-expressing IgMHEL and IgDHEL (blue) or MM4 transgenic mice
expressing only IgMHEL (green) or anergic B cells fromMD4:ML5 (red) or MM4:ML5 (orange) double-transgenic mice. Schematic of experimental strategy
shown in Supplementary Fig. 2. Symbols show individual recipients and columns arithmetic means. (a) Relative number of HEL-binding antigen receptors
per donor B cell before transfer, expressed as geometric mean fluorescence intensity (MFI, arbitrary units). (b) CFSE fluorescence histograms 2.5 days after
transfer and immunization, using gating strategy in Supplementary Fig. 3. Unshaded histograms show B220þCD45.1þ HEL-binding donor B cells in the
spleen, colour coded as in (a). To provide a reference for undiluted CFSE, dark shaded histograms are B220-negative CD45.1þ lymphocytes in recipients of
MD4 or MM4 cells. A reference for CFSE-negative cells is provided by the lightly shaded histograms from B220þCD45.1 recipient B cells. (c) Percentage
of donor B cells on day 2.5 with CFSE diluted to less than 1/16th of undivided donor cells. (d) Number of donor B cells in the spleen on day 2.5. (e) Number
of FasþCD38CD45.1þB220þ HEL-binding GC B cells in the spleen 5 days after transfer and immunization, using the gating strategy in Supplementary
Figs 4–6. There was no significant difference between the four groups in total GC B cells (CD45.1þ and CD45.1 ) as a % of B220þ cells (P¼0.17;
Supplementary Fig. 7). Statistical analysis by ANOVA with Bonferroni’s Multiple Comparison post-test: ns¼ not significant, *Po0.05, **Po0.01,
***Po0.001. Representative of two independent experiments. (f–h) Accumulation of mature anergic B cells with or without IgD in unimmunized double
transgenic mice. (f) Representative analyses of HEL-binding B220þ spleen cells, gated as shown in Supplementary Fig. 8, showing percentage of B cells in
indicated gates. (g,h) Percentage of all lymphocytes that are CD93CD23þ HEL-binding B220þ anergic B cells in the spleen of individual MD4:ML5 and
MM4:ML5 double transgenic mice (g) or in the blood of MD4:ML5 double transgenic mice with homozygous null or wild-type Zfp318 (h). Statistical
analysis by t-test, representative of two independent experiments.
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IgD promotes accumulation of mature anergic B cells. One
explanation for the results above was that IgD assists short-lived
anergic B cells to survive in the spleen long enough to respond to
foreign antigen and T cell help. Consistent with this hypothesis,
mature CD93CD23þ anergic B cells accumulated to much
lower frequency in the spleen of IgD-deficient MM4:ML5 double
transgenic animals compared with MD4:ML5 animals (Fig. 2f,g).
To exclude differences in transgene integration site between
the MD4 and MM4 animals, we also prevented IgD co-expression
in MD4:ML5 transgenic mice by breeding with a Zfp318 null
allele22. Accumulation of anergic mature B cells was diminished
in Zfp318 / MD4:ML5 transgenic mice where the B cells only
expressed IgMHEL (Fig. 2h).
IgD promotes accumulation independently of effects on IgM.
Diminished accumulation of mature anergic B cells in the
experiments above could reflect either a difference between
surface IgM and surface IgD in the way they trigger responses to
self-antigen, or a loss of the attenuating effect of IgD on
surface IgM levels, or both. In an ENU mutagenesis screen, we
discovered a surface IgD-deficient C57BL/6 mouse strain
with unaltered levels of surface IgM. The dimit strain (C57BL/
6JAnu-Ighddmit/Apb) has acquired a single T4A point mutation
resulting in an Ile81Lys substitution within the Cd1 exon
(Fig. 3a). Ile81 flanks Cys79 that forms the intradomain
disulphide bond and corresponds to an obligatory hydrophobic
residue at position 5 within b-sheet F of all Ig CH1 domains, part
of a folding nucleus of inward-pointing hydrophobic residues in
b-sheets B, C, E and F32,33. Ile81 mutation to charged,
hydrophilic lysine would be expected to prevent folding of the
IgD CH1 domain into the conformation needed to pair with
immunoglobulin light chains.
Surface IgD progressively increased on wild-type spleen B cells
between immature (CD93þCD23 transitional 1, T1), semi-
mature transitional cells (CD93þCD23þ T2 / T3 subset), and
mature follicular cells (CD93 CD23þ )34, but was decreased to
less than 5% of normal levels in Ighddmit/dmit homozygotes
(Fig. 3b,c). The mean surface IgM and the broad cell to cell
variance was nevertheless identical in Ighddmit/dmit homozygotes
and wild-type controls (Fig. 3c). This contrasts with the
aberrantly high cell surface IgM on B cells in IgD knockout or
Zfp318 knockout mice22,24,25, where IgD no longer competes with
IgM for assembly with CD79ab (refs 18,20). The loss of IgD and
normal surface IgM caused an overall 65% decrease in mean BCR
numbers on mature B cells (Fig. 3c).
The IgD point mutation enabled testing if loss of surface
IgD affected mature B cell accumulation independently from
IgD’s inhibitory effect on surface IgM levels. In heterozygous
Ighddmit/þmice, allelic exclusion resulted in 50% of the immature
T1, T2 and T3 B cells expressing the wildtype Ighd allele and 50%
expressing the mutant allele, the latter distinguished as IgDlow
cells by flow cytometry (Fig. 3b). By contrast, B cells expressing
the surface IgD-deficient allele contributed poorly to the mature B
cell repertoire and accounted for only 24% of cells (Fig. 3d). A
similar requirement for surface IgD for the accumulation of
mature B cells relative to immature B cells was observed in the
bone marrow, blood and spleen of mixed bone marrow chimeras
reconstituted with a mixture of CD45.1 and CD45.2 bone marrow
(Fig. 3e). The 52% decrease in mature B cells with the Ighddmit
mutation appears less than the decrease in mature anergic B cells
in MD4:ML5 transgenic mice with the Zfp318 mutation or the
decrease in MM4:ML5 anergic cells lacking IgD. This may reflect
the fact that the latter two lose two functions of IgD: surface IgD
display and IgD attenuation of surface IgM expression, whereas
the Ighddmit mutation selectively disrupts surface IgD.
IgD attenuates anergic B cell mRNA response to self-antigen.
We next performed a global RNA analysis of MD4 and MM4
naı¨ve and anergic mature B cells to test for any evidence that
surface IgD and IgM differ in their capacity to elicit responses to
self-antigen. Two variables differ between MD4:ML5 and
MM4:ML5 anergic B cells: (1) surface IgM is lower on MD4:ML5
cells because IgD competes with IgM for CD79 assembly
and surface expression; (2) the total cell surface pool of
antigen-binding receptors is higher on MD4:ML5 cells, because
IgD is not downregulated on anergic cells. The null hypothesis,
that there is no difference in the response to self elicited by
surface IgM and IgD, would therefore predict that there should
be no difference in the induction of anergy RNAs or there should
be less induction of some or all anergy RNAs in MM4:ML5 cells
because of their 65% fewer receptors for self-antigen. The
opposite result—a higher response to self by some or all of the
anergy-induced RNAs in MM4:ML5 cells without IgD—would
demonstrate that IgM is better at eliciting that part of the
response than IgD, and since IgD decreases surface IgM that
could further exaggerate any difference in the activity of the
surface receptors themselves. Much higher induction of all anergy
genes in MM4:ML5 cells, and little or no response to self-antigen
in MD4:ML5 cells, would be predicted based on the hypothesis
that IgD cannot signal to monomeric HEL (ref. 31).
Anergic and naı¨ve mature CD93CD23þ HEL-binding
splenic B cells were sorted from MD4:ML5 or MM4:ML5
mice and from MD4 or MM4 single-transgenic controls.
As an additional comparison, mature HEL-binding B cells
that expressed only IgDHEL were sorted from DD6:ML5 or
DD6 transgenic mice, which carry the same transgene as MD4
but missing the IgM exons26. RNA from independent donors
was measured on Agilent microarrays carrying 59,305 different
oligonucleotide probes for protein-coding and non-coding RNAs
(Supplementary Data 1). Analysis of constitutively expressed
mRNAs in B cells, exemplified by Cd19, Cd79b, B2m and Gapdh,
showed comparable expression regardless of BCR isotype or
exposure to self-antigen (Fig. 4a and Supplementary Fig. 11a).
In B cells that lose surface Ig completely, tonic BCR signals
through PI3-kinase are lost as evidenced by an increase in
mRNAs for four PI3-kinase repressed genes, Rag1, Cdkn1b,
Bcl2l11 and Aicda (ref. 35). Hence it was conceivable that the 65%
decrease in surface BCRs on anergic MM4:ML5 cells compared
with anergic MD4:ML5 cells or naı¨ve MM4 cells (Fig. 2a) might
also increase these mRNAs, but there was no evidence that this
was the case (Fig. 4a and Supplementary Fig. 11b).
We next analysed 18 mRNAs previously identified as being
consistently induced in anergic MD4:ML5 B cells using
first-generation Affymetrix arrays36. Twelve of these mRNAs
(Egr1, Egr2, Gfi1, Nab2, Cd83, Tgif1, Lck, Cd72, Nrgn, Ccnd2,
Crisp3 and Pcp4) were consistently increased in anergic B cells
relative to naı¨ve B cells, regardless of whether the B cells
co-expressed IgM and IgD or only expressed one isotype (Fig. 4a
and Supplementary Fig. 11c). Despite 62% fewer surface antigen
receptors on IgD-deficient anergic cells, Egr1, Egr2, Gfi1 and
Nab2 were paradoxically induced to 1.25–2.3 fold higher levels in
IgD-deficient MM4:ML5 anergic cells compared with IgDþ
MD4:ML5 anergic cells. The Egr2 paralogue, Egr3, and two other
genes shown previously to be induced in anergic B cells, Nr4a1
(NUR77(ref. 7)) and Sdc1 (CD138 (refs 37,38)), were also
induced to higher levels in MM4:ML5 IgD-deficient anergic
B cells (Fig. 4a and Supplementary Fig. 11d).
To obtain a comprehensive transcriptional landscape of
B cell anergy with and without IgD, we analysed all 59,305
oligonucleotide probes on the arrays. Using limma39, we focussed
on 33,653 probes that were positive for expression in anergic
B cells (Supplementary Data 2). Of these, 97 probes had strong
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evidence of at least two-fold increased expression in MD4:ML5
anergic B cells compared with MD4 naı¨ve counterparts, including
13 previously described anergy genes (Table 1 and Fig. 4b).
In this set of 97 probes, 91 and 78% had moderate or strong
evidence of induction in MM4:ML5 and DD6:ML5 anergic
B cells, respectively, compared with only 1 and 3% of all 33,653
expressed probes (Fig. 4c and Table 1). An additional 123 probes
had moderate evidence of induction in MD4:ML5, and
the majority were also induced in anergic B cells with only IgM
or only IgD (Table 1). Thus, when chronically stimulated by
monomeric self-HEL antigen in vivo, IgD expressed with IgM or
on its own induces the great majority of the transcriptional
response, in contrast to recent conclusions from a BLNK-
deficient pro-B cell line31.
Of 97 and 123 probes with strong and moderate evidence,
respectively, of induction in anergic cells co-expressing IgD and
IgM, 34 and 29% had moderate evidence of Z125% increased
expression in MM4:ML5 anergic cells lacking IgD compared with
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Figure 4 | Impact of IgD-deficiency on the anergic B cell gene expression program. Naı¨ve (N) or anergic (A) HEL-binding CD93CD23þ mature spleen
B cells were sorted from individual MD4 or MD4:ML5 (co-expressing IgMHEL and IgDHEL), MM4 or MM4:ML5 (only expressing IgMHEL), and DD6 or
DD6:ML5 (only expressing IgDHEL) transgenic mice, and mRNA analysed on Agilent microarrays. (a) Analysis by Agilent feature extraction software. Dots
show values and columns arithmetic means for indicated mRNA probes from independent mice per genotype, except DD6:ML5 where RNA was pooled
from three sorted donors. (b–d) Analysis by limma. (b) Y-axis, mean expression in all samples for 33,653 mRNA probes with positive expression in anergic
B cells. X-axis, mean and 95% confidence interval (CI) forZ2-fold change (FC, grey shaded region) in MD4:ML5 anergic cells relative to MD4 naı¨ve cells:
red, strong evidence; orange, moderate evidence; yellow, weak evidence; blue, very weak; black, no evidence. Black squares and gene symbols show mean
FC for previously identified anergy-induced mRNAs. (c) 220 probes with strong or moderate evidence of Z2-fold increase in MD4:ML5 anergic cells.
X-axis as in (b). Y-axis, mean and 95% CI ofZ2 FC in expression in MM4:ML5 anergic cells relative to MM4 naı¨ve cells. (d) 220 anergy-induced probes in
(c), showing mean and 95% CI of Z1.25 FC in MM4:ML5 anergic cells without IgD relative to MD4:ML5 anergic cells with IgD. Black squares and
accompanying gene symbols are previously identified anergy-induced mRNAs with differential expression in IgD-deficient anergic cells.
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MD4:ML5 anergic cells with IgD (Fig. 4d, Table 1). By contrast,
only 4% of the 33,653 expressed probes were increasedZ125% in
MM4:ML5 samples. The hyper-induced gene set in IgD-deficient
cells included mRNAs encoding transcription regulators
(Egr1, Egr2, Egr3, Gfi1, Lef1, Ahr, Myb, Myc, Nr4a1, Sox4,
Hmgn3, Apex1), apoptosis inducers (Casp4), and cell surface
proteins (Sdc1, Il18r1, Dlk1). Reciprocally, there was no evidence
for diminution of a subset of the anergy response without IgD:
only 5% of anergy induced genes were decreased without
IgD, which is comparable to 4% of all expressed probes on the
array showing similar evidence for decreased expression
(Table 1). Thus, IgD was not required for induction of the
anergy mRNA program but, paradoxically, its co-expression
increased the number of self-antigen binding receptors nearly
3-fold (Fig. 2a) yet attenuated one third of the mRNA response to
self-antigen.
Hyper-induction of EGR1, EGR2 and SDC1 proteins. We
validated the observations above by antibody staining and flow
cytometry, focussing on SDC1 because it is a cell surface
protein induced in B cells with chronically elevated intracellular
calcium38, and on the transcription factors EGR1 and EGR2,
which are induced in anergic B cells by the ERK and calcium-
calcineurin-NFAT signalling pathways, respectively4,36,40.
Anergic B cells from MD4:ML5 animals had significantly
increased EGR1 and EGR2 intracellular staining compared with
naı¨ve MD4 B cells, which served as a negative control B cell
population because they have very low Egr1 and Egr2 mRNA,
(Fig. 5a,b). Consistent with the microarray findings, there was
exaggerated induction of both proteins in IgD-deficient anergic
cells from MM4:ML5 animals (Fig. 5b, orange versus red
columns).
Cell surface staining confirmed that SDC1 was specifically
induced on immature, transitional and mature anergic
B cells from MD4:ML5 animals compared with naı¨ve MD4
B cells (Fig. 5c,d, red versus blue columns), and was induced to
higher levels on IgD-deficient anergic B cells from MM4:ML5
mice (Fig. 5d, orange columns). A similar level of SDC1 was
present on IgMlow splenic B cells in C57BL/6 mice with a diverse
antibody repertoire (Fig. 5c), consistent with evidence that surface
IgM downregulation identifies anergic self-reactive B cells in the
normal repertoire3–7.
IgD attenuates SDC1 induction independently of effect on IgM.
To extend these observations to the normal B cell repertoire, we
focussed on SDC1 because cell surface antibody staining could
readily detect its induction on individual B cells above
background autofluorescence. The increase in SDC1 and decrease
in surface IgM varied from cell to cell in a highly correlated way in
the immature T1, transitional T2/3, and mature follicular B cell
subsets (Fig. 6a). While surface IgM was unaltered in B cells from
homozygous Ighddmit mice, SDC1 was induced to higher mean
levels on the T2/3 and mature B cell subsets with little surface
IgD compared with wild-type controls with normal surface IgD
(Fig. 6b). When mature B cells were separated into four quartiles
based on the amount of surface IgM, mean SDC1 was higher on
surface IgD-deficient cells in each quartile (Fig. 6c). SDC1 levels
were also analysed in heterozygous Ighddmit/þ mice, where allelic
exclusion enabled comparison within individual animals between
the 50% of transitional IgMlow T3 B cells expressing the mutant
Ighd allele and the 50% with wild-type Ighd. SDC1 was induced to
higher levels on transitional B cells lacking surface IgD (Fig. 6d).
Thus surface IgD acts cell-autonomously to attenuate induction of
the SDC1 anergy marker on many semi-mature and mature B cells
in the normal repertoire, independently of IgD’s inhibitory effect
on surface IgM levels.
Discussion
The experiments above advance understanding of self-tolerance
and the role of IgD in six ways. First, they define 220 induced
RNA species that provide a comprehensive definition of the
anergic state in vivo, enabling future studies of how anergy is
distorted by susceptibility genes in autoimmunity or by mutations
in chronic lymphocytic leukaemia10 or lymphoma11. Second, the
Table 1 | Summary of microarray data analysed by limma.
Increased in MD4:ML5 anergic
relative to MD4 naive, strong
evidence
Increased in MD4:ML5 anergic relative to
MD4 naive, moderate evidence
All
expressed
genes
Number unique probes 97 123 33,653
Increased in MM4:ML5 anergic relative to
MM4 naive, mod or strong evidence
91% 76% 1%
Increased in DD6:ML5 anergic relative to
DD6 naive, mod or strong evidence
78% 61% 3%
Increased in MM4:ML5 anergic relative to
MD4:ML5 anergic, mod or strong evidence
34% 29% 4%
Decreased in MM4:ML5 anergic relative to
MD4:ML5 anergic, mod or strong evidence
5% 5% 4%
Gene Symbols: Increased in MM4:ML5
anergic relative to MD4:ML5 anergic
Myb, Gfi1, Egr2, NAP111439-1, Fabp5,
Sox4, Lef1, NAP114472-1, Endou, Shmt1,
Tacc2, Myc, Rasgef1a, Ms4a4a, Lzts2,
Sdc1, Faah, Egr1, Nab2, Ahr, Cenpv, Renbp,
Rapgef3, Nefh, Il4i1, LOC100040974,
Ppnr, Usp28, 9430078K24Rik, Gad1,
Apoe
chr17:35080914-35090009_R, 1110038B12Rik,
chr8:129336539-129400338_R, Tagap, Tagap1,
Egr3, Scn4a, ENSMUST00000103589, Ank,
Il18r1, Fam160a1, Echdc3, Car2, Psat1, Eno2,
Hmgn3, Slc43a3, Apex1, Casp4, Dhrs3, Vmp1,
Slc25a33, Chst7, Cldn10, Ppfibp2, Mcoln2, Prodh,
Dlk1, Ubash3b, A_65_P05803
Data for all 33,653 probes is provided in Supplementary Table 2.
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global RNA analysis reveals that IgD differs from IgM by
attenuating a large subset of the anergy response to self-antigen.
Third, the results of the RNA analysis and of calcium signalling
did not support previous conclusions that IgD signals for
B cell activation while IgM signals for tolerance28,29, that IgD
signals in a stronger and more sustained way than IgM (ref. 30),
nor that IgD is unable to signal to monovalent ligands31. Fourth,
flow cytometric staining for SDC1 reinforces the proposal that
IgM downregulation on many B cells in the normal repertoire
reflects an active anergic response to self3 and yields a method
to analyse and sort anergic B cells without engaging surface
IgM with antibodies3,4 nor requiring crosses to a transgenic
Nr4a1:GFP reporter strain7. Fifth, we discover a new mouse
mutant that eliminates surface IgD but retains the inhibitory
effect of IgD on surface IgM display, and show that the selective
loss of surface IgD results in exaggerated induction of SDC1 on
IgMlow anergic B cells. Finally, the experiments reveal that
IgD promotes accumulation of anergic B cells as mature
follicular B cells, thus minimizing tolerance-induced holes in
the pre-immune repertoire of antibodies available in secondary
lymphoid tissues.
Loss of surface IgD on transitional IgMlow T3 B cells decreases
the number of surface BCRs and would be expected to diminish
their response to self-antigen if IgM and IgD were functionally
equivalent, but paradoxically it increased the anergy response
reported by SDC1. Plasma cells with high levels of SDC1 are
absent in Prdm1 (Blimp-1) knockout mice but the subset of
SDC1low mature B cells analysed here are not plasma cells
because they form independently of Blimp-1 (ref. 41) and have
high B220 and CD19 that are both downregulated on
plasma cells. SDC1 is also induced on self-reactive B cells
binding the Smith ribonucleoprotein37. While MD4 B cells did
not express SDC1 in the absence of self-HEL (ref. 37), SDC1 was
spontaneously induced on MD4 naı¨ve B cells when their
intracellular calcium was chronically elevated by genetic
deficiency of inositol 1,4,5-trisphosphate 3-kinase b (Itpkb)38.
Repeated cycles of self-antigen binding in anergic cells raise
cytosolic calcium to 100–400 nM in an oscillatory manner, and
calcium reverts to the 50 nM baseline of naı¨ve B cells
when anergic cells are transplanted into recipients lacking the
self-antigen40 or when the self-antigen is outcompeted by a
non-stimulatory ligand for the BCR (ref. 42). Consistent with the
range of SDC1 induction between B cells in non-transgenic mice
and its correlation with surface IgM downregulation, intracellular
calcium is elevated to varying extents among polyclonal B cells
in proportion to their expression of an Nr4a1:GFP reporter
transgene7. Thus SDC1 serves as a convenient reporter for
the varying degrees of self-reactivity among B cells in the
pre-immune repertoire.
The attenuated self-antigen response when IgD is coexpressed
with IgM in vivo helps clarify earlier conflicting findings. A small
decrease in the proportion of mature B cells was observed
comparing a pair of transgenic strains expressing a polyreactive
BCR as IgM-only or as IgM and IgD (ref. 43). However, another
pair of transgenic mice with a slightly different H-chain V-region
displayed more mature B cells when bearing IgM-only than with
IgMþ IgD, although in these animals transitional IgM-only
B cells appeared more susceptible to deletion when exposed to a
tolerizing injection of human IgG antigen44. Mature B cells were
depleted by a tolerizing injection of TNP-dextran in IgM-only
IgSP6 transgenic mice, but not when these mice were crossed with
an IgD-only IgSP6 transgenic strain so that IgD was co-expressed
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with IgM (ref. 45). From these results it was hypothesized that
IgD attenuates tolerogenic signalling by IgM (ref. 46), consistent
with the findings here. Interpretation of these effects was
confounded by the absolute requirement for endogenous light
chain specificities for IgSP6 B cells to mature, and by rescue of
their maturation by injection of TNP-ficoll47.
A key question is how much the attenuation of the anergy
response by IgD demonstrated here reflects an intrinsic decrease
in the ability of IgD to signal in response to self-antigens and how
much reflects IgD inhibition of surface IgM for assembly
with CD79ab and trafficking to the cell surface18–21. The
experiments with the IgD dmit point mutant in Figs 3 and 6
show that exaggerated response to self-antigen still occurs when
IgD attenuates surface IgM normally but IgD is no longer
expressed on the surface of anergic cells. Thus IgD attenuates the
response to self-antigen in two ways: IgD is less able to elicit a
subset of the response than IgM on the cell surface, and IgD
decreases the display of surface IgM.
A simple explanation for the decreased signalling by IgD on the
surface has recently been proposed based on findings that IgD
was unable to signal an acute calcium response by monovalent
but not multivalent HEL antigen in a pro-B cell line where
the BLNK cytoplasmic signalling adaptor was expressed as an
oestrogen receptor-chimera that partially crippled BLNK function
by binding to heat shock proteins31. Four lines of evidence here
indicate this black and white difference between IgD and IgM
does not extrapolate to primary B cells with normal BLNK. First,
in primary B cells IgD was capable of inducing an acute calcium
response to monomeric HEL in vitro (Fig. 1). The initial calcium
peak was consistently slightly lower in IgDHEL B cells than in
IgMHEL B cells, and conceivably this subtle difference may be
exaggerated in cells with defective BLNK. Secondly, IgD was
competent to induce 78% of the anergy-induced RNA species in
response to monomeric HEL in vivo, including calcium-induced
genes like Egr2. Third, anergic IgMlow B cells in mice with a
normal antibody repertoire make antibodies binding to DNA and
other polymeric self-antigens4,6,7, making it unlikely that IgD
attenuation of SDC1 on a large fraction of these cells reflects
recognition of only monovalent self-antigens. Instead, IgD
appears to acquire the capacity to attenuate the response when
it is co-expressed with IgM. This might reflect competition
between the two receptor isotypes for particular signalling
molecules or membrane domains18,19,21,48,49.
The need for IgD to promote anergic B cell accumulation in the
spleen and blood may represent a mechanism to minimize holes
in the antibody repertoire created by self-tolerance. Deletion of
self-reactive B cells in the bone marrow, either by apoptosis or
receptor editing, removes antibody specificities from the
repertoire before they can be tested for binding to foreign
antigens. By contrast, antibodies on anergic B cells can be
hypermutated in germinal centres and selected for variants that
have lost binding to self but retain binding to foreign microbes13.
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Representative of two independent experiments and n¼ 8 animals.
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Methods
Mice. All mice were on a C57BL/6 background, male, mean age 157 days
(range 84–287 d), maintained in specific pathogen free conditions under a protocol
approved and monitored by the ANU Animal Experimentation and Ethics
Committee. MD4:ML5, MM4:ML5 and DD6:ML5 transgenic mice were as
described1,3,26. The Ighddmit strain was isolated by screening ENU-mutagenised
C57BL/6 mice for low surface IgD on blood B cells. The ENU-induced mutation
was identified by exome sequencing using the SureSelect Mouse Exome kit
(G7550A-001: Agilent, CA) and 100 bp paired-end sequencing on an Illumina
HySeq2500 following the manufacturers’ protocols. Allele-specific genotyping in
C57BL/6 backcrossed progeny was performed using Amplifluor assays (Chemicon,
Temecula, CA) and primers designed using the Assay architect online tool
(http://apps.serologicals.com/AAA/mainmenu.aspx; sequences available on
request). Zfp318 knockout mice were as described22. For ethical purposes, each
experiment used the minimum number of animals per group needed to provide
statistical power to detect a two-fold difference between groups, and each
experiment was performed multiple times. Animals from the same parents were
randomly assigned to experimental groups based on their genotype, but were not
blinded to the investigator. No animals were excluded from analysis.
Flow cytometry and sorting. Preparation of spleen cells and staining for
immature and mature B cells as described previously12,22, employing Efluor 780
fixable viability dye (eBioscience) and the following antibodies: B220, RA3-6B2
coupled to Alexafluor700 or APC-Cy7 (Becton Dickinson, 1/200); Fas, Jo-2
coupled to PE (Becton Dickinson), GL7 coupled to FITC (Becton Dickinson);
CD38, clone 90 coupled to PE (Biolegend), CD45.1, A20 coupled to Pacific Blue or
Alexfluor700 (Biolegend); CD45.2, 104 coupled to PerCP (Pharmingen); CD93,
AA4.1 coupled to FITC, APC or biotin (eBioscience, 1/100) or PE (Biolegend);
CD23, B3B4 coupled to PE (BD), PE-Cy7 (eBioscience, 1/200), or Pacific Blue
(Biolegend); IgD, 11-26c coupled to FITC or biotin (eBioscience, 1/100), PE
(Southern Biotech), PerCP-Cy5.5 or BV510 (Biolegend, 1/200); IgM, II/41 coupled
to APC or FITC (BD) or PE-Cy7 (eBioscience, 1/100); Streptavidin coupled to
PE-Cy7 or Qdot 605 (eBioscience). Each antibody conjugate and lot was titrated
and used at dilutions yielding saturated staining.
In Ig-transgenic mice, edited B cells were eliminated by gating out surface
IgKappahi HELlow B cells after staining with HEL followed by Hy9-APC (1/800)
and then anti-kappa monoclonal 187.1 conjugated to PerCP-Cy5.5 (Becton
Dickinson, 1/100). Staining for SDC1 employed biotinylated monoclonal antibody
281–2 followed by streptavidin-brilliant violet 605 (Biolegend). EGR1 and EGR2
staining was performed on fixed and permeabilised cells using the Foxp3 staining
kit (eBioscience), using rabbit monoclonal antibody T.126.1 (Thermo Scientific)
followed by anti-rabbit IgG CF405M polyclonal antibody (Sigma Aldrich) and
Erongr2-Phycoerythrin (eBioscience). CFSE labelling, adoptive transfer and
immunization with HEL-SRBC was as described12.
Microarray analysis. For microarray analysis, aliquots comprising 105 selected
cells were sorted into 15ml Falcon tubes containing 2ml foetal calf serum, on ice.
The cells were washed in PBS, resuspended in 1,400 ml PBS, transferred to 1.5ml
Eppendorf tubes, centrifuged at 900 g for 6min at 4 C, supernatants removed, and
tubes with cell pellets snap frozen in liquid N2, stored at  80 C, and all tubes
shipped together on dry ice to Miltenyi Biotec, Germany for processing and
microarray hybridization as a single batch.
Cell pellets were lysed and RNA isolated on NucleoSpin RNA II kits (Macherey-
Nagel) using standard protocols. RNA quality was analysed on an Agilent 2,100
Bioanalyzer and samples with RIN 46.4 were used. Cy3 labelled cRNA was
produced by linear T7-based amplification using the Agilent Low Input Quick
Amp Labelling Kit following the manufacturer’s protocol, and yields measured
with a Nanodrop ND-1,000 Spectrophotometer. 600 ng Cy3-labelled fragmented
cRNA was hybridized for 17 h at 65 C to Agilent Whole Mouse Genome Oligo
Microarrays 8 60K according to the Agilent 60-mer microarray processing
protocol. After washing, the arrays were scanned on an Agilent Microarray Scanner
System. The image files were analysed by two independent methods, Agilent
Feature Extraction Software and limma, with similar results. Using Agilent Feature
Extraction Software, signal intensities from individual features were normalized by
dividing by the median signal of all features on the same array, yielding the relative
mRNA units shown for selected probes in Fig. 1a and Supplementary Fig. 11, and
for all probes in Supplementary Data 1.
Using limma39 as detailed in Supplementary Methods, probe intensities were
corrected for background fluorescence using the normal-exponential convolution
model implemented by limma followed by cyclic loess normalization. Two low
quality samples were excluded from further limma analysis and from Agilent
analysis: one of three MM4 naı¨ve and one of three MM4:ML5 anergic samples. To
focus on B cell expressed genes, probes with a positive feature score in all
MD4:ML5 or MM4:ML5 samples were selected, yielding 33,653 anergic B cell
expressed probes (Supplementary Data 2). These were analysed for differential
expression between anergic and naı¨ve cells, or between anergic cells with and
without IgD. The estimated log2 fold change and 95% confidence interval (CI) were
computed. A minimum threshold was set for differential expression, with 2-fold
chosen for comparison of anergic and naı¨ve B cells, and 1.25-fold for comparing
anergic cells with or without IgD. Probes with CIs that overlapped this threshold
but had an estimated log fold change beyond the threshold were classed as having
moderate evidence of differential expression. Probes where the entire CI fell outside
the threshold were classed as having strong evidence of differential expression.
Data availability. Microarray data that support the findings of this study have
been deposited in GEO with the primary accession code GSE82091. All other data
that support the findings of this study are available from the corresponding author
on request.
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